ENTITY
HY07121
HY07121
PulseAugur coverage of HY07121 — every cluster mentioning HY07121 across labs, papers, and developer communities, ranked by signal.
Total · 30d
2
2 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
1
1 over 90d
TIER MIX · 90D
TOPICS
SENTIMENT · 30D
1 day(s) with sentiment data
RECENT · PAGE 1/1 · 2 TOTAL
-
Jiangshan Oupai Appoints New Board Secretary; Huiyu Pharma's Cancer Drug Trial Accepted
Jiangshan Oupai has appointed Chen Chunjin as the company's board secretary, effective immediately. This move means the company's chairman, Wu Shuigen, will no longer perform the duties of the board secretary. Separatel…
-
Huayu Pharmaceutical's novel triple-target cancer therapy gains clinical trial approval
Huayu Pharmaceutical's subsidiary, Huayu Haiyue, has received approval from China's National Medical Products Administration to begin clinical trials for HY07121, a novel subcutaneous injection for advanced solid tumors…